Clinical Trial Update: A Phase 2 Study to Determine the Effects of BXT-51072 in Diabetic Patients Undergoing Angioplasty (PCI) [Phase 2]

View source ↗

Summary

A Phase 2 trial of BXT-51072 in diabetic patients undergoing angioplasty (PCI) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Type 2 Diabetes Mellitus

Drugs mentioned

• BXT-51072

Snippet

Sponsor: Synvista Therapeutics, Inc | Conditions: Acute Coronary Syndrome, Type 2 Diabetes | Phase 2 | Status: COMPLETED